Opendata, web and dolomites

Cancer-Targeted PolyIC

Treatment of EGFR over-expressing cancers by targeted non-viral delivery of PolyIC

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Cancer-Targeted PolyIC project word cloud

Explore the words cloud of the Cancer-Targeted PolyIC project. It provides you a very rough idea of what is the project "Cancer-Targeted PolyIC" about.

kill    models    double    metastatic    cells    resembling    shir    rna    heterogeneous    local    preventing    expression    impressive    abourbeh    glioblastoma    egfr    antiproliferative    2006    tumors    infected    expressed    activates    capitalist    clinical    u87mgwtegfr    delivered    last    mda    spread    polyethylenimine    efficient    induce    shaffert    selective    homing    vectors    viruses    pro    disseminated    egf    cytokines    orthotropic    thereby    pic    deadly    poly    anti    breast    468    commercialization    cytosine    al    2012    bystander    cancers    fund    ifn    company    dsrna    mppe    therapy    frequently    synthetic    interferon    least    interferons    iosine    eliminated    agents    stranded    mb    et    polyethyleneglycol    half    overexpress    subcutaneous    apoptotic    melittin    shown    venture    systemic    overexpressing    2011    family    entities    simplified    cancer    proliferative    translated    mediated    mechanisms    simultaneously    wtegfr    virus    adenocarcinoma    a431    ready   

Project "Cancer-Targeted PolyIC" data sheet

The following table provides information about the project.

Coordinator
THE HEBREW UNIVERSITY OF JERUSALEM 

Organization address
address: EDMOND J SAFRA CAMPUS GIVAT RAM
city: JERUSALEM
postcode: 91904
website: www.huji.ac.il

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-PoC
 Funding Scheme ERC-POC
 Starting year 2015
 Duration (year-month-day) from 2015-02-01   to  2016-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE HEBREW UNIVERSITY OF JERUSALEM IL (JERUSALEM) coordinator 150˙000.00

Map

 Project objective

We have recently shown that application of EGFR targeted synthetic dsRNA: Poly Iosine/Poly Cytosine (pIC) is highly efficient and selective against deadly cancers overexpressing EGFR, like glioblastoma (U87MGwtEGFR), breast cancer (MDA-MB-468) and adenocarcinoma (A431). Double-stranded RNA, frequently expressed in cells infected with viruses, activates a number of pro-apoptotic processes simultaneously. These dsRNA-induced mechanisms efficiently kill infected cells and induce expression of anti-proliferative cytokines from the interferon (IFN) family, thereby preventing spread of the virus. pIC delivered with Melittin-polyethylenimine-polyethyleneglycol-EGF (MPPE) eliminated orthotropic and subcutaneous tumors of the above cancers. Heterogeneous glioblastoma models where only half of the cells overexpress wtEGFR are also eliminated by local application, most likely due to a bystander antiproliferative effects, at least partially mediated by interferons (Shir et al., 2006). Systemic application of EGFR targeted pIC is also highly effective against breast and adenocarcinoma disseminated cancer models resembling metastatic cancers (Shir et al., 2011). During the last two years we have improved the vectors homing to EGFR to entities that can now be translated into clinical agents (Shaffert, 2011; Shir 2011, Abourbeh 2012). The impressive results with these more simplified vectors, make this project ready for clinical development, which requires fund raising from a Company/Venture capitalist. Commercialization of the therapy will be detailed in the proposal.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CANCER-TARGETED POLYIC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CANCER-TARGETED POLYIC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

PLAT_ACE (2019)

A new platform technology for the on-demand access to large acenes

Read More  

TRUST (2018)

Truth and Semantics

Read More  

LO-KMOF (2019)

Vapour-deposited metal-organic frameworks as high-performance gap-filling dielectrics for nanoelectronics

Read More